Investigation on the Effect of Smoking on the Expression of Pro- and Anti-thrombotic, Anti-oxidative, and Inflammatory Markers in Humans

Inflammation Clinical Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT02198937
• Other study ID #: KEK-ZH-NR. 2014-0078
• Status: Terminated
• Phase: N/A
• First received: July 21, 2014
• Last updated: October 24, 2016
• Start date: June 2014
• Est. completion date: March 2016

Study information

• Verified date: October 2016
• Source: University of Zurich
• Contact: n/a
• Is FDA regulated: No
• Health authority: Switzerland: Ethikkommission Zürich
• Study type: Observational

Clinical Trial Summary

Investigation on the effect of smoking on thrombus formation in humans. The expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers will be assessed in 25-50 year old healthy smokers and non-smokers. The investigators are interested in possible differences between the two groups.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 10
• Est. completion date: March 2016
• Est. primary completion date: March 2016
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 25 Years to 50 Years

Eligibility

Inclusion Criteria:

• Smoker

• Non-smokers

Exclusion Criteria:

• Disease

• Pregnancy

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Inflammation
• Smoking
• Thrombosis

Intervention

Other:
• Blood sample

Locations

Country	Name	City	State
Switzerland	University Hospital	Zurich

Sponsors (1)

Lead Sponsor	Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Expression of pro- and anti-thrombotic, anti-oxidative, and inflammatory markers in blood		Single time point, no follow-up (cross sectional)	No